Your browser doesn't support javascript.
loading
EEG abnormalities in patients with chronic neuronopathic Gaucher disease: A retrospective review.
Poffenberger, Chelsie N; Inati, Sara; Tayebi, Nahid; Stubblefield, Barbara K; Ryan, Emory; Schiffmann, Raphael; Sidransky, Ellen; Lopez, Grisel.
Afiliação
  • Poffenberger CN; Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States of America.
  • Inati S; Electroencephalography (EEG) Section, Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States of America.
  • Tayebi N; Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States of America.
  • Stubblefield BK; Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States of America.
  • Ryan E; Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States of America.
  • Schiffmann R; Baylor Scott & White Research Institute, Dallas, TX, United States of America.
  • Sidransky E; Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States of America. Electronic address: sidranse@mail.nih.gov.
  • Lopez G; Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, United States of America.
Mol Genet Metab ; 131(3): 358-363, 2020 11.
Article em En | MEDLINE | ID: mdl-33183916
ABSTRACT
The clinical phenotype of Gaucher disease type 3 (GD3), a neuronopathic lysosomal storage disorder, encompasses a wide array of neurological manifestations including neuro-ophthalmological findings, developmental delay, and seizures including progressive myoclonic epilepsy. Electroencephalography (EEG) is a widely available tool used to identify abnormalities in cerebral function, as well as epileptiform abnormalities indicating an increased risk of seizures. We characterized the EEG findings in GD3, reviewing 67 patients with 293 EEGs collected over nearly 50 years. Over 93% of patients had some form of EEG abnormality, most consisting of background slowing (90%), followed by interictal epileptiform discharges (IEDs) (54%), and photoparoxysmal responses (25%). The seven patients without background slowing were all under age 14 (mean 6.7 years). There was a history of seizures in 37% of this cohort; only 30% of these had IEDs on EEG. Conversely, only 56% of patients with IEDs had a history of seizures. These observed EEG abnormalities document an important aspect of the natural history of GD3 and could potentially assist in identifying neurological involvement in a patient with subtle clinical findings. Additionally, this comprehensive description of longitudinal EEG data provides essential baseline data for understanding central nervous system involvement in neuronopathic GD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Convulsões / Epilepsias Mioclônicas / Doença de Gaucher / Malformações do Sistema Nervoso Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Female / Humans / Male Idioma: En Revista: Mol Genet Metab Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Convulsões / Epilepsias Mioclônicas / Doença de Gaucher / Malformações do Sistema Nervoso Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Child / Female / Humans / Male Idioma: En Revista: Mol Genet Metab Ano de publicação: 2020 Tipo de documento: Article